羥基磷灰石市場 - 全球產業規模、佔有率、趨勢、機會和預測，按類型、應用、地區和競爭細分，2019-2029F

2023 年全球羥基磷灰石市場價值為24.5 億美元，預計在預測期內將強勁成長，到2029 年複合年成長率為6.13%。鹽和一個羥基組成。它是牙齒的主要組成部分，具有比唾液高的硬度和更好的琺瑯質再礦化作用。

全球羥基磷灰石材料市場的擴張主要是由骨移植和骨移植材料需求不斷成長所推動的。需求激增主要是由幾個關鍵因素推動的，其中最主要的是美國和加拿大等地區人口結構向老化的轉變。隨著這些國家老年人口的穩定成長，對骨科植入物的需求也相應增加，從而成為羥基磷灰石市場成長的重要推動力。

例如，來自美國的資料顯示，僅在過去十年，老年人口就顯著增加了 33%，凸顯了對骨科干預措施的迫切需求，從而增加了對羥基磷灰石材料的需求。

新興經濟體和已開發國家可支配收入水準的上升導致消費者在化妝品上的支出增加，特別是抗衰老和護膚解決方案。這種不斷成長的消費者需求引發了全球產品組合和製造設施的快速擴張，從而提高了羥基磷灰石材料的市場佔有率。

北美和歐洲國家引入新的醫療服務預計將推動羥基磷灰石市場規模的成長。北美和歐洲國家將其 GDP 的很大一部分（約 11-15%）分配給醫療保健和研究機構，從而推動了市場的成長。例如，2018年，美國醫療保健支出增加了約4.6%。產品品質的進步促進了優質牙科和骨科植體的開發。例如，透過先進的溶膠-凝膠製程製備的羥基磷灰石在粒徑和塗層形成方面具有優勢，使其廣泛應用於眼部植入物和非整合植入物。

羥基磷灰石植入物的高成本和植入過程中涉及的幾種併發症預計將阻礙市場成長。與植入物相關的高成本和額外費用（例如材料包裹和釘更換）可能會導致對成本降低和併發症更少的多孔植入物的需求增加。

主要市場促進因素

醫療保健產業對羥基磷灰石的需求不斷成長

化妝品產業對羥基磷灰石的需求不斷成長

主要市場挑戰

優質原料供應有限

主要市場趨勢

生物相容性塗料的需求不斷成長

細分市場洞察

類型洞察

應用洞察

區域洞察

目錄

第 1 章：產品概述

第 2 章：研究方法

第 3 章：執行摘要

第 4 章：全球羥基磷灰石市場展望

• 市場規模預測
  • 按價值量
• 市佔率預測
  • 依類型（奈米尺寸、微米尺寸、大於微米）
  • 按應用（骨科、整形外科、牙科護理、其他）
  • 按地區
  • 按公司分類 (2023)
• 市場地圖
  • 按類型
  • 按申請
  • 按地區

第 5 章：亞太地區羥基磷灰石市場展望

• 市場規模預測
  • 按價值量
• 市佔率預測
  • 按類型
  • 按申請
  • 按國家/地區
• 亞太地區：國家分析
  • 中國
  • 印度
  • 澳洲
  • 日本
  • 韓國

第 6 章：歐洲羥基磷灰石市場展望

• 市場規模預測
  • 按價值量
• 市佔率預測
  • 按類型
  • 按申請
  • 按國家/地區
• 歐洲：國家分析
  • 法國
  • 德國
  • 西班牙
  • 義大利
  • 英國

第 7 章：北美羥基磷灰石市場展望

• 市場規模預測
  • 按價值量
• 市佔率預測
  • 按類型
  • 按申請
  • 按國家/地區
• 北美：國家分析
  • 美國
  • 墨西哥
  • 加拿大

第 8 章：南美洲羥基磷灰石市場展望

• 市場規模預測
  • 按價值量
• 市佔率預測
  • 按類型
  • 按申請
  • 按國家/地區
• 南美洲：國家分析
  • 巴西
  • 阿根廷
  • 哥倫比亞

第 9 章：中東與非洲羥基磷灰石市場展望

• 市場規模預測
  • 按價值量
• 市佔率預測
  • 按類型
  • 按申請
  • 按國家/地區
• MEA：國家分析
  • 南非
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國

第 10 章：市場動態

• 促進要素
• 挑戰

第 11 章：市場趨勢發展

• 最近的發展
• 產品發布
• 併購

第 12 章：全球羥基磷灰石市場：SWOT 分析

第 13 章：波特的五力分析

• 產業競爭
• 新進入者的潛力
• 供應商的力量
• 客戶的力量
• 替代產品的威脅

第14章：競爭格局

• Sofsera Corporation
• Taihei Chemical Industrial Co. Ltd
• Cam Bioceramics BV
• APS Materials Inc.
• Granulab (M) Sdn Bhd
• Berkeley Advanced Biomaterials Inc.
• Zimmer Biomet Holdings Inc
• CG Bio Inc.
• Bio-Rad Laboratories Inc.
• Fluidinova SA

第 15 章：策略建議

第 16 章：關於我們免責聲明

Global Hydroxyapatite Market was valued at USD2.45 billion in 2023 and is anticipated to project robust growth in the forecast period with a CAGR of 6.13% through 2029. Hydroxyapatite, the mineral form of calcium apatite, consists of one phosphate and one hydroxyl group. It is a major component of teeth, offering high rigidity and better enamel remineralization than saliva.

The expansion of the global hydroxyapatite materials market is predominantly fueled by the escalating demand for bone transplants and bone grafting materials. This surge in demand is notably propelled by several key factors, chief among them being the demographic shift towards an aging population in regions like the United States and Canada. As these nations witness a steady rise in the elderly population, there is a corresponding uptick in the requirement for orthopedic implants, thus acting as a significant driver for the growth of the hydroxyapatite market.

For instance, data from the United States reveals a notable increase of 33% in the elderly population over the past decade alone, underscoring the pressing need for orthopedic interventions and subsequently boosting demand for hydroxyapatite materials.

The escalation of disposable income levels in emerging economies as well as developed nations has resulted in heightened consumer spending on cosmetic products, particularly anti-aging and skincare solutions. This burgeoning consumer demand has triggered a rapid expansion of product portfolios and manufacturing facilities worldwide, consequently bolstering the market share of hydroxyapatite materials.

The introduction of new healthcare services in North America and European countries is anticipated to fuel the growth of the hydroxyapatite market size. Countries in North America and Europe are allocating a significant portion of their GDP, around 11-15%, to healthcare and research institutes, thus fueling the growth of the market. For instance, in 2018, the U.S. increased healthcare expenditure by around 4.6%. Advancements in product quality have led to the development of superior dental and orthopedic implants. For instance, hydroxyapatite prepared through an advanced sol-gel process provides advantages in terms of particle size and coating formation, making it widely applicable for ocular implants and non-integrated implants.

The high cost of hydroxyapatite implants and several complications involved in the implantation procedure are expected to hamper the market growth. The high cost associated with the implant and additional expenses, such as material wrapping and peg replacement, may lead to an increase in demand for porous implants with reduced cost and fewer complications.

Key Market Drivers

Growing Demand of Hydroxyapatite in Healthcare Industry

One of the key factors driving the demand for hydroxyapatite in the healthcare industry is the rising incidence of bone-related disorders such as osteoporosis and arthritis. As the global population ages, the prevalence of these conditions is expected to rise, thereby increasing the demand for effective treatment options. This is where hydroxyapatite-based implants and bone grafts come into play, offering a promising solution.

The use of hydroxyapatite is not just limited to orthopedics. It also finds extensive application in dental care. With advancements in dental care technologies and an increasing focus on oral hygiene, the demand for hydroxyapatite-based dental implants and toothpastes is on the rise. Hydroxyapatite-based dental implants provide a natural and aesthetically pleasing solution for tooth replacement, while hydroxyapatite toothpastes contribute to maintaining strong and healthy teeth.

There is an increased focus on the development and use of biocompatible implants in the healthcare industry. These are implants that can function in harmony with the human body without causing any adverse reactions. Hydroxyapatite, with its excellent biocompatibility, fits this requirement perfectly and hence, has seen a surge in demand. The ability of hydroxyapatite to integrate with surrounding tissues and promote bone regeneration makes it an ideal choice for various medical applications.

Growing Demand of Hydroxyapatite in Cosmetic Industry

Hydroxyapatite (HAp) is a naturally occurring mineral form of calcium apatite, known for its excellent biocompatibility and bioactivity. In the cosmetics industry, hydroxyapatite has emerged as a key ingredient in several products, particularly those related to dental and skincare applications.

Hydroxyapatite is gaining immense popularity in skincare products. It is used in anti-aging creams and serums due to its ability to support skin regeneration and collagen production. Nano-hydroxyapatite particles are used in sunscreens as they provide effective protection against harmful UV rays.

The global cosmetic industry has been witnessing a shift towards natural and sustainable products. Consumers are increasingly looking for products that are not only effective but also safe and eco-friendly. Hydroxyapatite, being a naturally occurring substance, aligns perfectly with this trend, thus driving its demand in the cosmetics sector.

The growing demand for hydroxyapatite in the cosmetic industry is a significant driver of the global hydroxyapatite market. As the cosmetic industry continues to evolve with an increased focus on natural and sustainable products, the demand for hydroxyapatite is expected to increase further, propelling the global market. This rise in demand is also attributed to the versatility of hydroxyapatite, as it finds applications not only in dental and skincare products but also in various other areas, such as tissue engineering. With ongoing research and development efforts, the potential of hydroxyapatite in the cosmetic industry is likely to expand, leading to further innovations and advancements in this field.

Key Market Challenges

Limited Availability of High-Quality Raw Materials

The global hydroxyapatite market has been experiencing significant growth in recent years, fueled by the increasing demand across various industries such as healthcare, cosmetics, and biotechnology. Amidst this growth, the hydroxyapatite industry also faces certain challenges that pose potential hindrances to its further development. One of the most prominent challenges is the limited availability of high-quality raw materials. Hydroxyapatite, being a naturally occurring mineral form of calcium apatite, heavily relies on the quality of its raw materials to determine the final product's properties and performance.

The global availability of such high-quality raw materials required for hydroxyapatite production is relatively limited. Several factors contribute to this limitation, including the depletion of natural resources, stringent environmental regulations, and geopolitical issues that affect mining operations. As a result, manufacturers often face challenges in sourcing the necessary raw materials, hampering the overall production capacity.

The limited availability of high-quality raw materials also affects the cost of production. As the demand for these materials surpasses the supply, prices tend to rise. This leads to increased production costs, which manufacturers may have to compensate for by either raising product prices or accepting reduced profit margins.

Key Market Trends

Growing Demand of Biocompatible Coatings

Biocompatible coatings refer to surfaces that are intricately designed to be in direct contact with living tissue without triggering any harmful reactions. These coatings are specifically engineered to ensure optimal compatibility, promoting seamless integration and functionality. One such remarkable material that exhibits exceptional biocompatibility and bioactivity is hydroxyapatite (HAp). Known as a naturally occurring mineral form of calcium apatite, HAp possesses unique properties that make it an ideal choice for creating biocompatible coatings.

The versatility of hydroxyapatite extends beyond orthopedic applications. Recent studies have shown promising results in utilizing hydroxyapatite coatings in cardiovascular applications. With the increasing prevalence of cardiovascular diseases, the demand for effective and biocompatible solutions is on the rise. Hydroxyapatite coatings have emerged as a potential solution, offering a combination of biocompatibility, durability, and performance.

The future of biocompatible coatings appears promising, driven by continuous advancements in the medical field and an unwavering focus on improving patient outcomes. As a result, the demand for hydroxyapatite is expected to experience significant growth, further propelling the expansion of the global hydroxyapatite market.

Segmental Insights

Type Insights

Based on the category of type, the nano-sized emerged as the fastest growing segment in the global market for hydroxyapatite in 2023.The concept of "nano-size hydroxyapatite" refers to the deliberate creation or alteration of hydroxyapatite particles, typically within the range of a few nanometers to several hundred nanometers. This specialized form of hydroxyapatite has become a focal point in the field of biomedicine, drawing considerable interest for its exceptional biocompatibility, osteoconductivity, and bioactivity.

Nano-sized hydroxyapatite holds immense potential across various applications within the biomedical sector. Its unique properties make it particularly well-suited for applications such as bone tissue engineering, where it can serve as a scaffold for promoting bone regeneration and repair. Its ability to interact favorably with biological systems makes it an ideal candidate for use in drug delivery systems, facilitating targeted and controlled release of pharmaceutical agents for enhanced therapeutic outcomes.

The exceptional biocompatibility of nano-sized hydroxyapatite ensures its compatibility with biological systems, minimizing adverse reactions and maximizing its usefulness in medical applications. Its osteoconductivity enables it to support bone growth and integration, making it an ideal candidate for bone tissue engineering.

Application Insights

The orthopedic segment is projected to experience rapid growth during the forecast period. The variables that contribute to an aging world population, such as increasing life expectancy and declining birth rates, along with the growing prevalence of age-related bone disorders and the rise in bone replacement procedures, are driving the demand for bioactive ceramics in the medical field. As the need for effective solutions for bone regeneration and restoration continues to grow, the market for bioactive ceramics is experiencing a significant surge in demand.

Regional Insights

North America emerged as the dominant player in the Global Hydroxyapatite Market in 2023, holding the largest market share in terms of both value and volume. In recent years, there has been a growing concern and awareness regarding dental health, leading to a significant 3.8% increase in the consumption of hydroxyapatite in North America. This rise can be attributed to the increasing focus on maintaining good oral hygiene and addressing dental issues in the region.

There has been a notable increase in expenditure to treat orthopedic issues, resulting in a 2.7% rise in the consumption of hydroxyapatite by the healthcare sector in North America. This indicates the growing recognition of hydroxyapatite's effectiveness in orthopedic treatments.

In Europe, the preference for cosmetic surgeries has been on the rise, leading to a 2.6% increase in demand for hydroxyapatite. This surge reflects the increasing desire for aesthetic enhancements and the trust placed in hydroxyapatite as a reliable component in cosmetic procedures. The research community has witnessed a boost in grants and scholarships dedicated to the study of ancient human lifestyle. As a result, there has been a 2.8% increase in the consumption of hydroxyapatite by research institutes, indicating its significance in conducting comprehensive studies and investigations.

Key Market Players

Sofsera Corporation

Taihei Chemical Industrial Co. Ltd

Cam Bioceramics BV

APS Materials Inc.

Granulab (M) Sdn Bhd

Berkeley Advanced Biomaterials Inc.

Zimmer Biomet Holdings Inc

CG Bio Inc.

Bio-Rad Laboratories Inc.

Fluidinova S.A.

Report Scope:

In this report, the Global Hydroxyapatite Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Hydroxyapatite Market,By Type:

• Nano-Sized
• Micro-Sized
• Greater than Micrometer

Hydroxyapatite Market,By Application:

• Orthopedic
• Plastic Surgery
• Dental Care
• Others

Hydroxyapatite Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Hydroxyapatite Market.

Available Customizations:

Global Hydroxyapatite Market report with the given market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1.Product Overview

• 1.1.Market Definition
• 1.2.Scope of the Market
  • 1.2.1.Markets Covered
  • 1.2.2.Years Considered for Study
  • 1.2.3.Key Market Segmentations

2.Research Methodology

• 2.1.Objective of the Study
• 2.2.Baseline Methodology
• 2.3.Key Industry Partners
• 2.4.Major Association and Secondary Sources
• 2.5.Forecasting Methodology
• 2.6.Data Triangulation Validation
• 2.7.Assumptions and Limitations

3.Executive Summary

• 3.1.Overview of the Market
• 3.2.Overview of Key Market Segmentations
• 3.3.Overview of Key Market Players
• 3.4.Overview of Key Regions/Countries
• 3.5.Overview of Market Drivers, Challenges, Trends

4.Global Hydroxyapatite Market Outlook

• 4.1.Market Size Forecast
  • 4.1.1.By Value Volume
• 4.2.Market Share Forecast
  • 4.2.1. By Type (Nano-Sized, Micro-Sized, Greater than Micrometer)
  • 4.2.2. By Application (Orthopedic, Plastic Surgery, Dental Care, Others)
  • 4.2.3. By Region
  • 4.2.4.By Company (2023)
• 4.3.Market Map
  • 4.3.1.By Type
  • 4.3.2.By Application
  • 4.3.3.By Region

5.Asia Pacific Hydroxyapatite Market Outlook

• 5.1.Market Size Forecast
  • 5.1.1.By Value Volume
• 5.2.Market Share Forecast
  • 5.2.1. By Type
  • 5.2.2. By Application
  • 5.2.3.By Country
• 5.3.Asia Pacific: Country Analysis
  • 5.3.1.China Hydroxyapatite Market Outlook
    • 5.3.1.1.Market Size Forecast
      • 5.3.1.1.1.By Value Volume
    • 5.3.1.2.Market Share Forecast
      • 5.3.1.2.1.By Type
      • 5.3.1.2.2.By Application
  • 5.3.2.India Hydroxyapatite Market Outlook
    • 5.3.2.1.Market Size Forecast
      • 5.3.2.1.1.By Value Volume
    • 5.3.2.2.Market Share Forecast
      • 5.3.2.2.1.By Type
      • 5.3.2.2.2.By Application
  • 5.3.3.Australia Hydroxyapatite Market Outlook
    • 5.3.3.1.Market Size Forecast
      • 5.3.3.1.1.By Value Volume
    • 5.3.3.2.Market Share Forecast
      • 5.3.3.2.1.By Type
      • 5.3.3.2.2.By Application
  • 5.3.4.Japan Hydroxyapatite Market Outlook
    • 5.3.4.1.Market Size Forecast
      • 5.3.4.1.1.By Value Volume
    • 5.3.4.2.Market Share Forecast
      • 5.3.4.2.1.By Type
      • 5.3.4.2.2.By Application
  • 5.3.5.South Korea Hydroxyapatite Market Outlook
    • 5.3.5.1.Market Size Forecast
      • 5.3.5.1.1.By Value Volume
    • 5.3.5.2.Market Share Forecast
      • 5.3.5.2.1.By Type
      • 5.3.5.2.2.By Application

6.Europe Hydroxyapatite Market Outlook

• 6.1.Market Size Forecast
  • 6.1.1.By Value Volume
• 6.2.Market Share Forecast
  • 6.2.1. By Type
  • 6.2.2. By Application
  • 6.2.3. By Country
• 6.3.Europe: Country Analysis
  • 6.3.1.France Hydroxyapatite Market Outlook
    • 6.3.1.1.Market Size Forecast
      • 6.3.1.1.1.By Value Volume
    • 6.3.1.2.Market Share Forecast
      • 6.3.1.2.1.By Type
      • 6.3.1.2.2.By Application
  • 6.3.2.Germany Hydroxyapatite Market Outlook
    • 6.3.2.1.Market Size Forecast
      • 6.3.2.1.1.By Value Volume
    • 6.3.2.2.Market Share Forecast
      • 6.3.2.2.1.By Type
      • 6.3.2.2.2.By Application
  • 6.3.3.Spain Hydroxyapatite Market Outlook
    • 6.3.3.1.Market Size Forecast
      • 6.3.3.1.1.By Value Volume
    • 6.3.3.2.Market Share Forecast
      • 6.3.3.2.1.By Type
      • 6.3.3.2.2.By Application
  • 6.3.4.Italy Hydroxyapatite Market Outlook
    • 6.3.4.1.Market Size Forecast
      • 6.3.4.1.1.By Value Volume
    • 6.3.4.2.Market Share Forecast
      • 6.3.4.2.1.By Type
      • 6.3.4.2.2.By Application
  • 6.3.5.United Kingdom Hydroxyapatite Market Outlook
    • 6.3.5.1.Market Size Forecast
      • 6.3.5.1.1.By Value Volume
    • 6.3.5.2.Market Share Forecast
      • 6.3.5.2.1.By Type
      • 6.3.5.2.2.By Application

7.North America Hydroxyapatite Market Outlook

• 7.1.Market Size Forecast
  • 7.1.1.By Value Volume
• 7.2.Market Share Forecast
  • 7.2.1. By Type
  • 7.2.2. By Application
  • 7.2.3.By Country
• 7.3.North America: Country Analysis
  • 7.3.1.United States Hydroxyapatite Market Outlook
    • 7.3.1.1.Market Size Forecast
      • 7.3.1.1.1.By Value Volume
    • 7.3.1.2.Market Share Forecast
      • 7.3.1.2.1.By Type
      • 7.3.1.2.2.By Application
  • 7.3.2.Mexico Hydroxyapatite Market Outlook
    • 7.3.2.1.Market Size Forecast
      • 7.3.2.1.1.By Value Volume
    • 7.3.2.2.Market Share Forecast
      • 7.3.2.2.1.By Type
      • 7.3.2.2.2.By Application
  • 7.3.3.Canada Hydroxyapatite Market Outlook
    • 7.3.3.1.Market Size Forecast
      • 7.3.3.1.1.By Value Volume
    • 7.3.3.2.Market Share Forecast
      • 7.3.3.2.1.By Type
      • 7.3.3.2.2.By Application

8.South America Hydroxyapatite Market Outlook

• 8.1.Market Size Forecast
  • 8.1.1.By Value Volume
• 8.2.Market Share Forecast
  • 8.2.1. By Type
  • 8.2.2. By Application
  • 8.2.3.By Country
• 8.3.South America: Country Analysis
  • 8.3.1.Brazil Hydroxyapatite Market Outlook
    • 8.3.1.1.Market Size Forecast
      • 8.3.1.1.1.By Value Volume
    • 8.3.1.2.Market Share Forecast
      • 8.3.1.2.1.By Type
      • 8.3.1.2.2.By Application
  • 8.3.2.Argentina Hydroxyapatite Market Outlook
    • 8.3.2.1.Market Size Forecast
      • 8.3.2.1.1.By Value Volume
    • 8.3.2.2.Market Share Forecast
      • 8.3.2.2.1.By Type
      • 8.3.2.2.2.By Application
  • 8.3.3.Colombia Hydroxyapatite Market Outlook
    • 8.3.3.1.Market Size Forecast
      • 8.3.3.1.1.By Value Volume
    • 8.3.3.2.Market Share Forecast
      • 8.3.3.2.1.By Type
      • 8.3.3.2.2.By Application

9.Middle East and Africa Hydroxyapatite Market Outlook

• 9.1.Market Size Forecast
  • 9.1.1.By Value Volume
• 9.2.Market Share Forecast
  • 9.2.1. By Type
  • 9.2.2. By Application
  • 9.2.3.By Country
• 9.3.MEA: Country Analysis
  • 9.3.1.South Africa Hydroxyapatite Market Outlook
    • 9.3.1.1.Market Size Forecast
      • 9.3.1.1.1.By Value Volume
    • 9.3.1.2.Market Share Forecast
      • 9.3.1.2.1.By Type
      • 9.3.1.2.2.By Application
  • 9.3.2.Saudi Arabia Hydroxyapatite Market Outlook
    • 9.3.2.1.Market Size Forecast
      • 9.3.2.1.1.By Value Volume
    • 9.3.2.2.Market Share Forecast
      • 9.3.2.2.1.By Type
      • 9.3.2.2.2.By Application
  • 9.3.3.UAE Hydroxyapatite Market Outlook
    • 9.3.3.1.Market Size Forecast
      • 9.3.3.1.1.By Value Volume
    • 9.3.3.2.Market Share Forecast
      • 9.3.3.2.1.By Type
      • 9.3.3.2.2.By Application

10.Market Dynamics

• 10.1.Drivers
• 10.2.Challenges

11.Market Trends Developments

• 11.1.Recent Developments
• 11.2.Product Launches
• 11.3.Mergers Acquisitions

12.Global Hydroxyapatite Market: SWOT Analysis

13.Porter's Five Forces Analysis

• 13.1.Competition in the Industry
• 13.2.Potential of New Entrants
• 13.3.Power of Suppliers
• 13.4.Power of Customers
• 13.5.Threat of Substitute Product

14.Competitive Landscape

• 14.1. Sofsera Corporation
  • 14.1.1.Business Overview
  • 14.1.2.Company Snapshot
  • 14.1.3.Products Services
  • 14.1.4.Financials (As Reported)
  • 14.1.5.Recent Developments
• 14.2. Taihei Chemical Industrial Co. Ltd
• 14.3. Cam Bioceramics BV
• 14.4. APS Materials Inc.
• 14.5. Granulab (M) Sdn Bhd
• 14.6. Berkeley Advanced Biomaterials Inc.
• 14.7. Zimmer Biomet Holdings Inc
• 14.8. CG Bio Inc.
• 14.9. Bio-Rad Laboratories Inc.
• 14.10. Fluidinova S.A.

15.Strategic Recommendations

16.About Us Disclaimer